SOTAX PHARMA SERVICES S.A.
Prior to joining SPS Pharma Services, Samir spent more than 10 years at Sandoz and Novartis, participating to the development of analytical methods for residues of agrochemical compounds (using GC-MS or LC-MS, as well as automated sample preparation platforms such as Zymark Benchmate) or to the development of several pharmaceutical products, particularly in charge of the development of dissolution methods.
In 2005, he resigned from Novartis to create SPS Pharma Services in Clermont Ferrand which is the first and only CRO specialized in Dissolution and Release Testing.
There, Samir managed SPS facility and was in charge of projects management.
In April 2013, SPS Pharma Services moved to a new larger facility in Orleans (France) in order to ensure better efficiency and provide a broader range of services to its clients, including cGMP routine testing.
The facility has been successfully inspected by US FDA and is registered as Pharmaceutical Establishment for both US and Europe
Since beginning of 2022, SPS has been fully integrated within SOTAX Group and Samir is now in charge of the whole business segment Pharma Services, which comprises of 3 sites located in Europe, America and Asia.
Fields of interest and expertise: analytical development, in vitro dissolution and release testing (all techniques from USP1 to USP7), in vitro-in vivo correlations (IVIVC), formulation development, laboratory automation.
- In Vitro Release Testing of Non-oral Complex Dosage Forms
28 March 11:30 am Arena 3